XML 15 R4.htm IDEA: XBRL DOCUMENT v3.22.4
Condensed Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Jan. 28, 2023
Jan. 29, 2022
Jan. 28, 2023
Jan. 29, 2022
Income Statement [Abstract]        
Net sales $ 184,975 $ 139,558 $ 544,334 $ 448,767
Cost of sales 143,262 117,250 445,123 362,007
Gross profit 41,713 22,308 99,211 86,760
Operating expenses:        
Selling 12,908 12,735 41,866 37,012
General and administrative 9,861 8,328 27,989 24,100
Product design and development 7,250 6,925 21,655 21,283
Goodwill impairment 4,576 0 4,576 0
Operating expenses 34,595 27,988 96,086 82,395
Operating income (loss) 7,118 (5,680) 3,125 4,365
Nonoperating (expense) income:        
Interest (expense) income, net (398) 56 (721) 134
Other expense, net (1,380) (793) (2,335) (2,613)
Income (loss) before income taxes 5,340 (6,417) 69 1,886
Income tax expense (benefit) 1,627 (2,067) 14,666 177
Net income (loss) $ 3,713 $ (4,350) $ (14,597) $ 1,709
Weighted average shares outstanding:        
Basic (in shares) 45,387 45,223 45,320 45,263
Diluted (in shares) 45,448 45,223 45,320 45,442
Earnings (loss) per share:        
Basic (in usd per share) $ 0.08 $ (0.10) $ (0.32) $ 0.04
Diluted (in usd per share) $ 0.08 $ (0.10) $ (0.32) $ 0.04